Search
for
Sort by
Research 31–60 of 1000+
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Cutaneous Reactions to Drugs
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Séquelles cutanéomuqueuses et oculaires des SJS et de Lyell
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Wnt Signaling Across Adult Skin Mini-Organs: Interfollicular Epidermis, Hair Follicle, and Nail—Implications for Disease and Regeneration
- Chemotherapy and Cutaneous Drug Reactions
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- A Review of the Use of Biotin for Hair Loss
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Supportive Cryotherapy: A Review From Head to Toe
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Chronic toxicity of 3,4,3′,4′-tetrachlorobiphenyl in the marmoset monkey (Callithrix jacchus)